IMO--- summary of the last 5 years.
Removing Matt/wife saved approx. $400,000 a year
Lawsuit with St.George/Tonquint, settled and paid off--increases bottom line by approx, 1,000,000 a year
Vincente contract paid off--approx, 120,000 to bottom line
Morgan resigns--Snow is his replacement--$120,000 minus $60,000-- Aprrox. $60,000 to bottom line
China/Banco gone--savings unknown-- sale of Biocells adds approx.$50,000 to bottom line
CCEL buying approx 10% of shares
Red Oak $725,000 for 30% of shares, all going to pay off debt
25,000 to 30,000 samples valued at Approx $25 to $30,000,000
o/s of 1,272,066,146 shares unchanged for approx 2 years
Approx $1,000,000 in cash
Approx $55,000,000 tax carryover
loss of 12% of tissue business
loss of AABB accreditation
outsourcing to unknown 3rd party
loss of mesenchymal cells
Mr.Sandberg, IMO until CBAI is sold, acquired, or merged-- to increase share value-- increase revenue by having the sales dept, aggressively going after hospitals, universities, research centers, pharma, and blood bank groups. and buy back between $75,000 and $100,000 shares a month. I have approx $60,000 invested in CBAI since 2005. Lets see some action.
